These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19434062)

  • 1. Report from London.
    Kirby R
    Prostate Cancer Prostatic Dis; 2009; 12(2):105. PubMed ID: 19434062
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
    Schröder FH; Roobol MJ
    BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150
    [No Abstract]   [Full Text] [Related]  

  • 3. [What to remember about prevention and screening].
    Davin JL
    Soins; 2007 Mar; (713):56. PubMed ID: 17419580
    [No Abstract]   [Full Text] [Related]  

  • 4. What's new in prostate cancer screening and prevention?
    Klein EA
    Cleve Clin J Med; 2009 Aug; 76(8):439-45. PubMed ID: 19652036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of prostatic carcinoma: pros and cons].
    Terrone C; De Luca S; Chiapello G
    Recenti Prog Med; 2000 Nov; 91(11):559-61. PubMed ID: 11125947
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer: current evidence weighs against population screening.
    Boyle P; Brawley OW
    CA Cancer J Clin; 2009; 59(4):220-4. PubMed ID: 19564244
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer screening.
    Sandblom G; Varenhorst E
    Cancer Causes Control; 2008 Dec; 19(10):1411. PubMed ID: 18521712
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is prostate cancer screening necessary?].
    Nau JY
    Rev Med Suisse; 2008 Jun; 4(160):1417. PubMed ID: 18630068
    [No Abstract]   [Full Text] [Related]  

  • 9. What's hot in the prostate?
    Gleave M; Evans CP
    Prostate Cancer Prostatic Dis; 2004; 7(4):273-6. PubMed ID: 15592439
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors, prevention and early detection of prostate cancer.
    Loeb S; Schaeffer EM
    Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cancer screening guidelines say less is more.
    McBride D
    ONS Connect; 2009 Apr; 24(4):19. PubMed ID: 19413237
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer screening: why it's not for every man.
    Lakhan SE
    Medscape J Med; 2008; 10(8):182; author reply 182. PubMed ID: 18924634
    [No Abstract]   [Full Text] [Related]  

  • 13. Weighing the benefits and downsides of prostate-specific antigen screening.
    Pignone M
    Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
    [No Abstract]   [Full Text] [Related]  

  • 14. New trial data do not end the PSA screening debate.
    Vastag B
    J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary intervention--a rewarding challenge in nursing.
    Aspholm D
    Urol Nurs; 1991 Dec; 11(4):21-3. PubMed ID: 1776016
    [No Abstract]   [Full Text] [Related]  

  • 16. Europeans collaborate on screening trials for prostate cancer.
    Reynolds T
    J Natl Cancer Inst; 1995 Jun; 87(12):868-71. PubMed ID: 7666473
    [No Abstract]   [Full Text] [Related]  

  • 17. Instant experience in clinical trials: a novel aid to teaching by simulation.
    Maxwell C; Domenet JG; Joyce CR
    J Clin Pharmacol New Drugs; 1971; 11(5):323-31. PubMed ID: 4935713
    [No Abstract]   [Full Text] [Related]  

  • 18. [Screening for prostate cancer: results from the first screening round in the French population of the ERSPC trial].
    Richard F
    Prog Urol; 2009 Jul; 19(7):499-500. PubMed ID: 19559381
    [No Abstract]   [Full Text] [Related]  

  • 19. Slow progress in prostate cancer.
    Wyllie MG
    BJU Int; 2007 Mar; 99(3):695-6. PubMed ID: 17407523
    [No Abstract]   [Full Text] [Related]  

  • 20. The hazards of intermediate endpoints.
    Beer TM; Ryan CW
    Cancer; 2007 Nov; 110(9):1877-9. PubMed ID: 17849427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.